Bulletin
Investor Alert

New York Markets Close in:

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

Market open

 --Real time quotes

Nov 12, 2019, 11:59 a.m.

/zigman2/quotes/209129655/composite

$

20.94

Change

-0.98 -4.47%

Volume

Volume 1.23m

Real time quotes

/zigman2/quotes/209129655/composite

Previous close

$ 21.92

$ 20.94

Change

-0.98 -4.47%

Day low

Day high

$20.80

$21.90

Open

52 week low

52 week high

$20.20

$120.40

Open

Company Description

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extract...

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Valuation

P/E Current

-28.71

P/E Ratio (with extraordinary items)

-19.79

Price to Sales Ratio

135.76

Price to Book Ratio

33.25

Enterprise Value to EBITDA

-37.39

Enterprise Value to Sales

21.40

Total Debt to Enterprise Value

0.07

Efficiency

Revenue/Employee

62,689.00

Income Per Employee

-98,435.00

Receivables Turnover

4.40

Total Asset Turnover

0.12

Liquidity

Current Ratio

21.37

Quick Ratio

20.75

Cash Ratio

19.96

Profitability

Gross Margin

29.39

Operating Margin

-133.67

Pretax Margin

-167.34

Net Margin

-157.02

Return on Assets

-19.06

Return on Equity

-70.25

Return on Total Capital

-17.13

Return on Invested Capital

-21.50

Capital Structure

Total Debt to Total Equity

217.11

Total Debt to Total Capital

68.47

Total Debt to Total Assets

65.35

Long-Term Debt to Equity

216.87

Long-Term Debt to Total Capital

68.39

Officers and Executives

Name Age Officer Since Title
Mr. Brendan Kennedy 46 2018 President, Chief Executive Officer & Director
Mr. Greg Christopher - 2019 Executive Vice President-Operations
Mr. Mark Castaneda 54 2018 Chief Financial Officer & Treasurer
Dr. Joshua Eades - 2014 Chief Science Officer & Vice President
Ms. Alexandra Cremonese - 2019 Manager-International Sourcing & Development

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/01/2019 Brendan Kennedy
President and CEO; Director
18,461   Derivative/Non-derivative trans. at $24.18 per share. 446,386
10/01/2019 Edward Wood Pastorius
Chief Revenue Officer
2,749   Derivative/Non-derivative trans. at $24.18 per share. 66,470
10/01/2019 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
10/01/2019 Michael Shtender-Auerbach
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
10/01/2019 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2019 Maryscott Greenwood
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2019 Rebekah Dopp
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2019 Christine Thompson St. Clare
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
07/18/2019 Mark Castaneda
CFO, Secretary, Treasurer
78,700   Derivative/Non-derivative trans. at $43.41 per share. 3,416,367
07/18/2019 Mark Castaneda
CFO, Secretary, Treasurer
200,000   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2019 Brendan Kennedy
President and CEO; Director
15,403   Derivative/Non-derivative trans. at $49.3 per share. 759,367
07/01/2019 Edward Wood Pastorius
Chief Revenue Officer
1,761   Derivative/Non-derivative trans. at $49.3 per share. 86,817
07/01/2019 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2019 Michael Shtender-Auerbach
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2019 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0
06/20/2019 Maryscott Greenwood
Director
667   Disposition at $50.01 per share. 33,356
06/20/2019 Rebekah Dopp
Director
3,938   Disposition at $50 per share. 196,900
06/20/2019 Christine Thompson St. Clare
Director
4,000   Disposition at $50.01 per share. 200,040
06/01/2019 Maryscott Greenwood
Director
8,750   Derivative/Non-derivative trans. at $0 per share. 0
06/01/2019 Rebekah Dopp
Director
8,750   Derivative/Non-derivative trans. at $0 per share. 0
06/01/2019 Christine Thompson St. Clare
Director
8,750   Derivative/Non-derivative trans. at $0 per share. 0
04/15/2019 Mark Castaneda
CFO, Secretary, Treasurer
10,000   Disposition at $51.72 per share. 517,200
04/15/2019 Mark Castaneda
CFO, Secretary, Treasurer
10,000   Derivative/Non-derivative trans. at $7.76 per share. 77,600
04/05/2019 Edward Wood Pastorius
Chief Revenue Officer
3,443   Disposition at $61.04 per share. 210,160
04/02/2019 Brendan Kennedy
President and CEO; Director
18,970   Disposition at $63.78 per share. 1,209,906
04/02/2019 Edward Wood Pastorius
Chief Revenue Officer
2,807   Disposition at $63.78 per share. 179,030
04/01/2019 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2019 Brendan Kennedy
President and CEO; Director
50,000   Derivative/Non-derivative trans. at $7.76 per share. 388,000
04/01/2019 Michael Shtender-Auerbach
Director
8,750   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2019 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2019 Edward Wood Pastorius
Chief Revenue Officer
43,750   Derivative/Non-derivative trans. at $7.76 per share. 339,500
04/01/2019 Brendan Kennedy
President and CEO; Director
1,842   Disposition at $64.73 per share. 119,232
04/01/2019 Brendan Kennedy
President and CEO; Director
32,539   Disposition at $63.84 per share. 2,077,289
04/01/2019 Brendan Kennedy
President and CEO; Director
52,758   Disposition at $63.03 per share. 3,325,336
04/01/2019 Edward Wood Pastorius
Chief Revenue Officer
3,062   Disposition at $64.8 per share. 198,417
04/01/2019 Edward Wood Pastorius
Chief Revenue Officer
6,600   Disposition at $64.14 per share. 423,324
04/01/2019 Edward Wood Pastorius
Chief Revenue Officer
34,088   Disposition at $63.08 per share. 2,150,271
/news/latest/company/us/tlry

MarketWatch News on TLRY

  1. Cronos kicks off cannabis earnings with revenue miss but stock gains

    20 min ago

    - Ciara Linnane

  2. Marijuana Stocks Have Been Pummeled. But One Analyst Still Sees Opportunities.

    7:00 a.m. Today

    - Connor Smith

  3. Cannabis earnings: How much worse can it get for underperforming weed companies?

    6:53 a.m. Today

    - Max A. Cherney

  4. Walmart, weed and a couple of crucial tech earnings are coming your way

    6:53 a.m. Today

    - Jeremy C. Owens

  5. Marijuana Grower Tilray Reports Earnings Today. Here’s What to Expect.

    5:30 a.m. Today

    - Connor Smith

  6. Cronos Is Small Enough to Weather Weed’s Winter

    10:10 a.m. Nov. 11, 2019

    - Bill Alpert

  7. Loading more headlines...
/news/nonmarketwatch/company/us/tlry

Other News on TLRY

  1. Aphria Stock: Best of a Bad Lot?

    10:28 a.m. Today

    - InvestorPlace.com

  2. China on board with hemp, but not marijuana

    10:09 a.m. Today

    - Seeking Alpha

  3. Wall Street Breakfast: Shots Fired In Streaming Wars

    7:01 a.m. Today

    - Seeking Alpha

  4. 5 Trendy Earnings Charts

    5:53 p.m. Nov. 11, 2019

    - Zacks.com

  5. Tilray Q3 2019 Earnings Preview

    5:30 p.m. Nov. 11, 2019

    - Seeking Alpha

  6. High Hopes: Tilray Stock Needs a Miracle to Finish 2019 Strong

    7:00 a.m. Nov. 11, 2019

    - InvestorPlace.com

  7. Alibaba And Disney Step Out (Stocks To Watch Podcast)

    7:30 a.m. Nov. 10, 2019

    - Seeking Alpha

  8. Stocks To Watch: Alibaba And Disney Step Out

    7:09 a.m. Nov. 9, 2019

    - Seeking Alpha

  9. Investors Should Use Other Metrics to Evaluate Cronos Group Stock

    12:02 p.m. Nov. 8, 2019

    - InvestorPlace.com

  10. 7 Earnings Reports to Watch Next Week

    11:38 a.m. Nov. 8, 2019

    - InvestorPlace.com

  11. Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?

    10:32 a.m. Nov. 7, 2019

    - Zacks.com

  12. The Bubble Has Burst, But Tilray Stock Is More Than a Penny Stock

    2:59 p.m. Nov. 6, 2019

    - InvestorPlace.com

  13. Aurora Cannabis Stock Demonstrates Promising Trading Opportunities

    11:23 a.m. Nov. 6, 2019

    - InvestorPlace.com

  14. Why the Slide of Tilray Stock May Continue

    8:52 a.m. Nov. 6, 2019

    - InvestorPlace.com

  15. Loading more headlines...

At a Glance

Tilray, Inc.

1100 Maughan Road

Nanaimo, British Columbia V9X IJ2

Phone

1 8448457291

Industry

Farming

Sector

Agriculture

Fiscal Year-end

12/2019

Revenue

$43.13M

Net Income

$-67.72M

2018 Sales Growth

110.0%

Employees

688.00

/news/pressrelease/company/us/tlry

Press Releases on TLRY

  1. Financial Institutions Take Note of Cannabis Market's Glowing Potential

    9:00 a.m. Today

    - PR Newswire - PRF

  2. Legal Marijuana Market | Here�'s are Something That Must You Know

    4:55 p.m. Nov. 8, 2019

    - HTF Market Intelligence

  3. IntelGenx Reports Third Quarter 2019 Financial Results

    4:01 p.m. Nov. 7, 2019

    - GlobeNewswire

  4. IntelGenx Reports Third Quarter 2019 Financial Results

    4:01 p.m. Nov. 7, 2019

    - GlobeNewswire

  5. The Top Global Growth Stories Creating a $130 Billion Cannabis Opportunity

    11:15 a.m. Oct. 21, 2019

    - Financial News Media

  6. Loading more headlines...
Link to MarketWatch's Slice.